Cited by 165Metabolism, Diabetes, and CancerNeuroscience and Neuropharmacology ResearchBarrier Structure and Function Studies

ENZYMIC AND CEREBRAL METABOLIC EFFECTS OF 2‐DEOXY‐d‐GLUCOSE

Horton, R. W., Meldrum, B. S., Bachelard, H. S.·1973·Journal of Neurochemistry

Abstract

—The time course of effects of 2‐deoxy‐d‐glucose on cerebral glucose metabolism has been studied in vivo and the inhibitory actions of 2‐deoxy‐d‐glucose and 2‐deoxy‐d‐glucose‐6‐phosphate on cerebral glycolytic enzymes in vitro. Mice were given 2‐deoxy‐d‐glucose 3 g/kg intraperitoneally. Blood 2‐deoxy‐d‐glucose/glucose ratio was 2–3 from 5 to 30 min after injection, the hyperglycaemic response to 2‐deoxy‐d‐glucose having been suppressed with propranolol. Maximal cerebral 2‐deoxy‐d‐glucose uptake observed was 1μ11 μmol/g/min between 5 and 10 min after injection. At 10 min brain concentrations of 2‐deoxy‐d‐glucose and 2‐deoxy‐d‐glucose‐6‐phosphate were 5·82 and 3·12 μmol/g. Analysis of the fate of d‐[U‐14 C] glucose given subcutaneously 5 min before death showed that glucose uptake was reduced to 40–60 per cent of control from 5 to 30 min after 2‐deoxy‐d‐glucose. However brain glucose concentration rose three to five‐fold 20–30 min after 2‐deoxy‐d‐glucose. The majority of glucose entering the brain after 10 min of 2‐deoxy‐d‐glucose treatment was recovered as glucose. Conversion of brain glucose to other acid soluble components was reduced to 1/3 at 10 min and 1/5 at 20–30 min. Glucose‐6‐phosphate concentration rose from 5 min onwards and was maintained at twice control concentration from 10–30 min. However, because of the rapid entry of 2‐deoxy‐d‐glucose and its conversion to 2‐deoxy‐d‐glucose‐6‐phosphate, the 2‐deoxy‐d‐glucose 6‐P/glucose 6‐P ratio was between 19 and 32. Brain adenosine triphosphate concentration did not change, creatine phosphate concentration fell after 25 min. Measurement of enzyme activities in cerebral homogenates (using 1 mivs substrate concentration) showed that hexokinase (EC 2.7.1.1) was 40 per cent inhibited by 5 m m‐deoxy‐d‐glucose (but not by 2‐deoxy‐d‐glucose 6‐P). Glucose 6‐P dehydrogenase (EC 1.1.1.49), 6‐phosphogluconate dehydrogenase (EC 1.1.1.43) and phosphoglucomutase (EC 2.7.5.1) were not affected by either 2‐deoxy‐d‐glucose (5 m m) or 2‐deoxy‐d‐glucose 6‐P (5 or 20 m m). Hexose‐phosphate isomerase (EC 5.3.1.9) was 70 per cent inhibited by 20 m m‐d‐deoxy‐d‐glucose 6‐P. Phosphofructokinase (EC 2.7.1.11) was inhibited by 17 per cent by 2‐deoxy‐d‐glucose 6‐P (20 m m). During the initial impairment of cerebral function by 2‐deoxy‐d‐glucose there is competitive inhibition of glucose transport into the brain; later, glycolysis is more powerfully depressed by the inhibition of isomerase produced by the high intracerebral concentration of 2‐deoxyglucose‐6‐phosphate.

Integrity signals

Registry

Crossref · 10.1111/j.1471-4159.1973.tb05996.x

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Horton, R. W., Meldrum, B. S., & Bachelard, H. S.
Affiliations
Medical Research Council (GB)
Venue
Journal of Neurochemistry
Publisher
Wiley
Published
1973-09
Volume
21
Issue
3
Pages
507-520
ISSN
  • 0022-3042 (ISSN-L)
  • 1471-4159
OpenAlex
W2043889745
Cited by
165
References
1
Citations by year
2026: 1 · 2025: 2 · 2024: 2 · 2023: 4 · 2022: 4 · 2021: 1 · 2020: 1 · 2019: 3 · 2018: 1 · 2017: 2 · 2016: 2 · 2015: 6 · 2014: 2 · 2013: 2 · 2012: 1
FWCI
0.97
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Neurochemistry (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
  • Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
Keywords
2-deoxyglucose, brain glucose metabolism, glycolytic enzymes, glucose-6-phosphate, brain glucose uptake, hyperglycemia, propranolol, phosphocreatine, ATP, enzyme inhibition, glucose-6-phosphatase, glucose-6-phosphate dehydrogenase, glucose-1-phosphate
MeSH terms
Adenosine Triphosphate, Animals, Blood Glucose, Body Temperature, Carbon Radioisotopes, Cerebral Cortex, Chromatography, Ion Exchange, Deoxy Sugars, Glucose, Glucosephosphate Dehydrogenase, Glucose-6-Phosphate Isomerase, Glucosephosphates, Glycolysis, Guinea Pigs, Hexokinase, Male, Phosphocreatine, Phosphofructokinase-1, Phosphoglucomutase, Phosphogluconate Dehydrogenase, Propranolol, Mice, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review